Potential effectiveness of parenteral nemonoxacin in the treatment of Clostridioides difficile infections: in vitro, ex vivo, and mouse studies
The potential role of nemonoxacin, which can be administered parenterally, for treating CDIs was evidenced through the <i>in vitro</i>, <i>ex vivo</i>, and mouse models.
Authors
- Pei‐Jane Tsai (ORCID: https://orcid.org/0000-0001-9938-3299)
- Yuan‐Pin Hung (ORCID: https://orcid.org/0000-0003-1006-705X)
- Hung‐Tsung Wu (ORCID: https://orcid.org/0000-0002-0611-8427)
- Wen‐Chien Ko (ORCID: https://orcid.org/0000-0001-7497-149X)
- Ching‐Chi Lee (ORCID: https://orcid.org/0000-0002-4949-2742)
- Xiang-Zhe Yan
Institutions
- Chest Hospital, Ministry of Health and Welfare (TW)
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2024-08-20
- DOI
- https://doi.org/10.3389/fmicb.2024.1418817
- Citations
- 1
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- National Cheng Kung University Hospital
- National Cheng Kung University
- National Science and Technology Council